SION

NASDAQ · Biotechnology

Sionna Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.87

-0.13 (-3.25%)

As of Nov 7, 1:48 AM ET ·

Analyst Consensus

Hold

Analysts

High

Coverage

Buy 6 35%

Hold 11 65%

Sell 0 0%

Price Target

Analyst Price Target +547.5% upside

Low Target $14.18

Average Target $25.06

High Target $26.23

Current Price $3.87

Current
$3.87

Target
$25.06

$14.18 $25.06 avg $26.23

Scenario Analysis

Bear Case

$14.18

266.4%

Low target

Base Case

$25.06

+547.5%

Avg target

Bull Case

$26.23

+577.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$54.97

-93.0% from high

52-Week Low

$3.25

+19.1% from low

Target vs 52W High

$25.06

-54.4% vs high

Next Earnings Report

Nov 11, 2026

until earnings

EPS Est: $-0.62

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%